F&P Healthcare posts highest half-year profit yet
But currency and competition risks remain for the medical device maker - with special audio feature.
Click the NBR Radio box for on-demand special feature audio: New F&P product pipeline exciting, says Macquarie senior investment adviser Brad Gordon
Medical device maker F&P Healthcare [NZX: FPH] has recorded its highest half-year profit yet, after increasing its product range and global sales.
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Fri, 27 Nov 2015
Fri, 27 Nov 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
F&P Healthcare posts highest half-year profit yet
53874